Literature DB >> 18590041

Analysis of survival in HIV-infected subjects according to socio-economic resources in the HAART era.

G Liotta1, G M Caleo, S Mancinelli.   

Abstract

Availability of Highly Active Anti-Retroviral Treatment (HAART) has modified the natural history of HIV infection, resulting in increase of seropositive subjects survival. The aim of the study was to assess patients' survival in relation to socio-economic status in HAART era using Functional Multidimensional Evaluation questionnaire. A three-level Socio-Economic Index (SEI) combining results from self-perception of unmet needs and objective data from the assessment of the two dimensions has been set up by the authors. Of the 382 subjects interviewed, 102 had been lost to follow-up. SEI showed that 66.4% of the sample faced unmet social or economic needs and 17.1% had unmet needs in both areas. There was a significant relationship between the self-sufficiency in performing Activities of Daily Living (ADL), Clinical Staging, CD4 cell count, SEI and risk of death. The lowest level of SEI was associated with a doubled risk of death compared to SEI upper level. Availability of social and economics support have a positive effect upon survival in patients with HIV infection, also in case of availability of HAART. The combination of subjective and objective assessment of socio-economic resources allows a better understanding of their impact on survival.

Entities:  

Mesh:

Year:  2008        PMID: 18590041

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  2 in total

1.  Socioeconomic Status and Survival of People with Human Immunodeficiency Virus Infection before and after the Introduction of Highly Active Antiretroviral Therapy: A Systematic Literature Review.

Authors:  Elena Pavlova-McCalla; Mary Jo Trepka; Gilbert Ramirez; Theophile Niyonsenga
Journal:  J AIDS Clin Res       Date:  2012-07-20

2.  Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting.

Authors:  Giorgio L Colombo; Antonella Castagna; Sergio Di Matteo; Laura Galli; Giacomo Bruno; Andrea Poli; Stefania Salpietro; Alessia Carbone; Adriano Lazzarin
Journal:  Ther Clin Risk Manag       Date:  2013-12-18       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.